Using your tracking data to improve type 2 diabetes care
Patient-generated health data connections to empower diabetes management success
A web tool that combines your continuous glucose, activity, and medication reports to help adults with type 2 diabetes set goals and manage daily blood sugar.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11296940 on NIH RePORTER |
What this research studies
I would use the MPower Hub web platform that pulls in my continuous glucose monitor and activity tracker data plus my own reports about medication and daily habits. The platform shows interactive visualizations designed to help me see how behaviors affect my glucose and to increase motivation to change. It then prompts me to choose specific behavior goals and makes action plans using proven self-regulation techniques. This pilot project will refine the program and how it works for adults with type 2 diabetes before larger testing.
Who could benefit from this research
Good fit: Adults aged 21 and older with type 2 diabetes who use or are willing to use continuous glucose monitors and activity trackers and who want help with daily self-management.
Not a fit: People without access to or interest in using wearable glucose or activity monitors, those with type 1 diabetes, or those unable to use web-based tools may not benefit.
Why it matters
Potential benefit: If successful, this could help people with type 2 diabetes better link daily behaviors to blood sugar and make lasting self-care changes that reduce complications.
How similar studies have performed: Other programs using CGM feedback and behavior-change coaching have shown promise for improving glucose and habits, but this specific integrated MPower Hub platform is novel and being optimized.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Rosland, Ann-Marie — University of Pittsburgh at Pittsburgh
- Study coordinator: Rosland, Ann-Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.